NKX2-5 and pulmonary arterial hypertension: Quantification of NKX2-5 expression revealed that over 70% of cells expressed NKX2-5 in PAH patient pulmonary arteries/arterioles (20–100 μm in diameter) compared with less than 10% of cells in vessels from control lungs (Figure 1C).